Paloma Partners’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-32,292
| Closed | -$628K | – | 1860 |
|
|
2018
Q1 | $628K | Sell |
32,292
-1,052
| -3% | -$20.5K | 0.01% | 805 |
|
|
2017
Q4 | $555K | Buy |
+33,344
| New | +$555K | 0.01% | 751 |
|
|
2017
Q2 | – | Sell |
-57,730
| Closed | -$730K | – | 1967 |
|
|
2017
Q1 | $730K | Buy |
57,730
+3,156
| +6% | +$39.9K | 0.01% | 988 |
|
|
2016
Q4 | $723K | Buy |
54,574
+38,627
| +242% | +$512K | 0.01% | 926 |
|
|
2016
Q3 | $378K | Buy |
15,947
+4,836
| +44% | +$115K | ﹤0.01% | 1070 |
|
|
2016
Q2 | $320K | Buy |
+11,111
| New | +$320K | ﹤0.01% | 1301 |
|
|
2016
Q1 | – | Sell |
-8,136
| Closed | -$348K | – | 1763 |
|
|
2015
Q4 | $348K | Sell |
8,136
-8,787
| -52% | -$376K | 0.01% | 923 |
|
|
2015
Q3 | $596K | Buy |
16,923
+12,277
| +264% | +$432K | 0.01% | 669 |
|
|
2015
Q2 | $213K | Sell |
4,646
-8,661
| -65% | -$397K | ﹤0.01% | 1315 |
|
|
2015
Q1 | $624K | Sell |
13,307
-17,222
| -56% | -$808K | 0.02% | 594 |
|
|
2014
Q4 | $967K | Buy |
+30,529
| New | +$967K | 0.04% | 365 |
|
|
2014
Q2 | – | Sell |
-8,538
| Closed | -$226K | – | 1220 |
|
|
2014
Q1 | $226K | Buy |
+8,538
| New | +$226K | 0.01% | 514 |
|
|
2013
Q4 | – | Sell |
-17,300
| Closed | -$355K | – | 1255 |
|
|
2013
Q3 | $355K | Buy |
+17,300
| New | +$355K | 0.01% | 577 |
|